Finance

Beta
Lists
LYRA:OTCMKTS
Lyra Therapeutics Inc
$0.55
-8.36%
(-0.050) 1D
Jun 12, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for LYRA...
Open
$0.60
High
$0.71
Low
$0.55
Mkt. cap
976.51K
Avg. vol.
11.13K
Volume
40.51K
52-wk high
$14.88
52-wk low
$0.31
EPS
-$18.62
Beta
0.70
Shares outstanding
1.78M
No. of employees
27
Open
$0.60
High
$0.71
Low
$0.55
Mkt. cap
976.51K
Avg. vol.
11.13K
Volume
40.51K
52-wk high
$14.88
52-wk low
$0.31
EPS
-$18.62
Beta
0.70
Shares outstanding
1.78M
No. of employees
27
News stories
From sources across the web
About Lyra Therapeutics Inc
CEO-
Employees27
Founded2005
HeadquartersWatertown, Massachusetts, United States
SectorPharmaceutical industry
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
183.00K
183.00K
25.00K
7.00K
Cost of goods sold
4.88M
5.11M
4.05M
-13.03M
Cost of revenue
4.88M
5.11M
4.05M
-13.03M
Research and development expenses
-
-
-
17.40M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.26M
3.50M
2.24M
2.54M
Operating expense
3.26M
3.50M
2.24M
19.94M
Total operating expenses
8.14M
8.61M
6.28M
6.92M
Operating income
-7.96M
-8.43M
-6.26M
-6.91M
Other non operating income
-
-
-
-
EBT including unusual items
-8.54M
-7.44M
-5.98M
-6.95M
EBT excluding unusual items
-7.66M
-8.02M
-6.00M
-6.74M
Income tax expense
4.00K
2.00K
3.00K
2.00K
Effective tax rate
-0.05%
-0.03%
-0.05%
-0.03%
Other operating expenses
-
-
-
-
Net income
-8.55M
-7.44M
-5.98M
-6.95M
Net profit margin
-4,670.49%
-4,063.93%
-23,936.00%
-99,300.00%
Earnings per share
-
-5.22
-3.40
-
Interest and investment income
298.00K
410.00K
256.00K
169.00K
Interest expense
-
-
-
-
Net interest expenses
298.00K
410.00K
256.00K
169.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.83M
-8.30M
-6.15M
-6.81M
Gain or loss from assets sale
-
-8.00K
-
-
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more